A poorly characterized protein, historically thought to be a chaperon or enzyme, may actually be a key player in prostate ...

A research team from the University of Osaka, in collaboration with the Massachusetts Institute of Technology, has uncovered ...

Clustered regularly interspaced palindromic repeats(CRISPR) gene editing, known for its precision, is revolutionizing tumor research and treatment. This article covers the evolution of the CRISPR ...

A study harnessing a successful treatment for lymphoma and applying it to other cancers promises a breakthrough in how to attack a range of tumours using the body’s own immune system.

A research team from The University of Osaka, in collaboration with the Massachusetts Institute of Technology, has uncovered a new molecular mechanism underlying chromosome alignment during cell ...

Osaka, Japan - A research team from The University of Osaka, in collaboration with the Massachusetts Institute of Technology, ...

Positive Phase 1 data for CTX310® presented in a late-breaking presentation at the American Heart Association (AHA) ...

Technology opens the door to more accurate preclinical testing, which could enable the development of safer and more effective therapies.

A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate ...

How can altering DNA help defeat one of the world’s deadliest diseases? This video explores how scientists are using CRISPR ...